4th Quarter - Report

SQUIRE PATTON BOGGS for GENENTECH, INC.

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY14 appropriations bills, including issues related to FDA funding and drug approval/review oversight process; and sequestration process. Issues related to comprehensive tax reform, tax treatment of foreign-owned U.S. corporations, and tax extenders, including R&D tax credit. Corporate tax reform issues. International trade issues and patent protection abroad.

Foreign entity interest: Same as client

LobbyistCovered position, as disclosed
KEVIN O'NEILL —
MANNY ROSSMAN Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.